{"transactions":[{"id":4125551,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":164258,"kind":"person","name":"Leach Kevin","position":1,"cik":"0001668805","reported_name":"Leach Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President Marketing"}}],"security":"Restricted Stock Units","published_at":"2017-12-20T23:53:56.000Z","date":"2017-12-18","kind":"grant","acquired":true,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date."}],"balance_after":1400,"derivative":{"underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001179110-17-015741","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017015741/edgar.xml","form_type":"4"}},{"id":4125550,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":164258,"kind":"person","name":"Leach Kevin","position":1,"cik":"0001668805","reported_name":"Leach Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President Marketing"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2017-12-20T23:53:56.000Z","date":"2017-12-18","kind":"grant","acquired":true,"shares":8250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of AxoGen, Inc. common stock underlying the employee stock option will be fully vested on December 18, 2021 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":8250,"derivative":{"exercise_price":27,"expiration_date":"2027-12-18","underlying":"Common Stock","underlying_shares":8250},"source":{"system":"sec-edgar","filing":"0001179110-17-015741","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017015741/edgar.xml","form_type":"4"}},{"id":4509014,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":164258,"kind":"person","name":"Leach Kevin","position":1,"cik":"0001668805","reported_name":"Leach Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President Marketing"}}],"security":"Employee Stock Option (right to purchase)","published_at":"2017-01-03T21:43:14.000Z","date":"2016-12-29","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of Common Stock underlying the employee stock option will be fully vested on December 29, 2020(4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 29, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter."}],"balance_after":45000,"derivative":{"exercise_price":8.95,"expiration_date":"2026-12-29","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001179110-17-000078","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911017000078/edgar.xml","form_type":"4"}},{"id":4579915,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":164258,"kind":"person","name":"Leach Kevin","position":1,"cik":"0001668805","reported_name":"Leach Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President Marketing"}}],"security":"Common Stock","published_at":"2016-10-14T19:14:17.000Z","date":"2016-10-07","kind":"purchase","acquired":true,"shares":2000,"price":7.5,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchased these shares in his individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On October 7, 2016, the trade date for the public offering, the closing sale price reported by NASDAQ was $9.15 per share. The public offering closed on October 13, 2016 and the closing sale price reported by NASDAQ on such date was $8.72 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person purchased these shares in his individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On October 7, 2016, the trade date for the public offering, the closing sale price reported by NASDAQ was $9.15 per share. The public offering closed on October 13, 2016 and the closing sale price reported by NASDAQ on such date was $8.72 per share."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001179110-16-030714","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911016030714/edgar.xml","form_type":"4"}}]}